Vital Signs - 5 September 2006

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on September 5, 2006, provides a strategic overview of the potential benefits of increasing the utilization of pre-clinical imaging in drug development. Additionally, an emerging company profile is provided for Visual Sonics, a leading developer of high resolution in vivo micro imaging systems designed for animal research. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of August 21 - August 25, 2006

Table of Contents

Vital Signs - 5 September 2006Pre-clinical Imaging: Unparalleled Molecular Detail Can be the Future of Accelerating Drugs To MarketPre-clinical Imaging: Unparalleled Molecular Detail Can be the Future of Accelerating Drugs To Market




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 30-Oct-17

Region : North America

Release Date : 25-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.